Hui‐Fen Liao
- Cancer Research top 5%
- Beetle Biology and Toxicology Studies 14
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 6
- Enzyme Catalysis and Immobilization 4
- Microbial Metabolic Engineering and Bioproduction 4
- Insect Science top 5%
- Biotechnology top 5%
-
- Coleoptera Taxonomy and Distribution 6
-
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 4
-
- Cancer-related Molecular Pathways 5
- Co-authors
- Yu-Jen ChenChwen‐Jen ShiehCheng‐Deng KuoYuh‐Cheng YangMing‐Shi ShiaoSan‐Lang WangYue‐Horng YenK. S. Clifford Chao
- Journals
- Anti-Cancer Drugs (6 papers)Evidence-based Complementary and Alternative Medicine (5 papers)Food and Chemical Toxicology (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hui‐Fen Liao
76 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 430
- Complementary and alternative medicine 142
- Molecular Biology 1.0k
- Insect Science 170
- Biotechnology 118
Countries citing papers authored by Hui‐Fen Liao
This map shows the geographic impact of Hui‐Fen Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Fen Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Fen Liao more than expected).
Fields of papers citing papers by Hui‐Fen Liao
This network shows the impact of papers produced by Hui‐Fen Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Fen Liao. The network helps show where Hui‐Fen Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui‐Fen Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 21 | |
| 4 | 2019 | 4 | |
| 5 | 2018 | 16 | |
| 6 | 2016 | 2 | |
| 7 | 2014 | 24 | |
| 8 | 2014 | 13 | |
| 9 | 2012 | 20 | |
| 10 | 2011 | 8 | |
| 11 | 2009 | 1 | |
| 12 | 2009 | 68 | |
| 13 | 2009 | 44 | |
| 14 | 2008 | 43 | |
| 15 | 2006 | 32 | |
| 16 | 2006 | 18 | |
| 17 | 2006 | 127 | |
| 18 | 2005 | 53 | |
| 19 | 2003 | 219 | |
| 20 | CYCLODESIPEPTIDE AND DIOXOMORPHOLINE DERIVATIVES ISOLATED FROM THE INSECT- BODY PORTION OF THE FUNGUS CORDYCEPS CICADAE | 2002 | 13 |
About Hui‐Fen Liao
Hui‐Fen Liao is a scholar working on Cancer Research, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 79 papers that have together received 2.1k indexed citations. Recurring topics across this work include Beetle Biology and Toxicology Studies (14 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Coleoptera Taxonomy and Distribution (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer-related Molecular Pathways (5 papers), Enzyme Catalysis and Immobilization (4 papers), Immune Cell Function and Interaction (4 papers) and Microbial Metabolic Engineering and Bioproduction (4 papers). The work is most often cited by research in Cancer Research (430 citations), Complementary and alternative medicine (142 citations) and Molecular Biology (1.0k citations). Hui‐Fen Liao has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yu-Jen Chen, Chwen‐Jen Shieh, Cheng‐Deng Kuo, Yuh‐Cheng Yang, Ming‐Shi Shiao, San‐Lang Wang, Yue‐Horng Yen, K. S. Clifford Chao, Tung‐Hu Tsai and Yu‐Chieh Su. Their work appears in journals such as Anti-Cancer Drugs, Evidence-based Complementary and Alternative Medicine, Food and Chemical Toxicology, The American Journal of Chinese Medicine and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.